Denise A. Figlewicz on ERBB4 Mutations that Disrupt the Neuregulin-ErbB4 Pathway Cause Amyotrophic Lateral Sclerosis Type 19.
COMMENT This new discovery is exciting. In addition to the welcome identification of another critical player in the pathogenesis of ALS, ErbB receptor tyrosine kinases and neuregulins are much-studied groups of molecules, so there should be a lot of resources ...